大脑中动脉动脉瘤介入治疗临床价值探析

Clinical Value of Interventional Therapy for Middle Cerebral Aneurysm

目的探讨大脑中动脉动脉瘤(MCAA)介入治疗临床价值。方法回顾性分析2017年1月至2022年12月我中心采用不同介入治疗方式干预的102例MCAA患者的临床及影像学资料,随访分析手术成功率、并发症发生率、再出血率、复发率等指标。结果102例患者中,手术成功率达到98.04%,术中载瘤动脉和支架内血栓6例,血栓率5.88%。术中破裂2例,破裂率1.96%。术后随访无动脉瘤再破裂出血。3例单纯栓塞和2例支架辅助栓塞出现瘤颈复发,复发率约4.5%。结论MCAA介入治疗在临床应用中具有明显的价值,是一种安全有效的微创治疗方法,疗效较好。但尚需要加大样本量进一步验证。

Objective To explore the clinical value of interventional treatment of middle cerebral artery aneurysm(MCAA).Methods We retrospectively analyzed the clinical and imaging data of 102 patients with MCAA who were intervened with different interventional modalities in our center from January 2017 to December 2022,and followed up to analyze the indexes of success rate of the procedure,complication rate,rebleeding rate,and recurrence rate.Results Among the 102 patients,the success rate of operation was 98.13%.There were 6 cases of parent artery and stent thrombus during operation,and the thrombus rate was 5.8%.Intraoperative rupture occurred in 2 cases,with a rupture rate of 1.9%.0 cases of ruptured aneurysm were followed up after operation.Tumor neck recurrence occurred in 3 cases of simple embolization and 2 cases of stent-assisted embolization,and the recurrence rate was about 4.5%.Conclusion MCAA interventional therapy has obvious value in clinical application.It is a safe and effective minimally invasive treatment method with good curative effect.However,it is necessary to increase the sample size to further verify the above conclusions.